All terms in GO
| Label | Id | Description |
|---|---|---|
| subtelomeric heterochromatin formation | GO_0031509 |
The compaction of chromatin into heterochromatin at the subtelomeric region.
|
| Tea1 cell-end complex | GO_0031500 |
A high molecular weight complex characterized in S. pombe containing the cell-end anchoring protein Tea1. This complex is transported to the cell ends by microtubules and is involved in bipolar growth and the maintennce of normal cell polarity.
|
| localization | GO_0051179 |
Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported, tethered to or otherwise maintained in a specific location. In the case of substances, localization may also be achieved via selective degradation.
|
| peptidoglycan-based cell wall organization | GO_0031504 |
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the peptidoglycan-based cell wall.
|
| fungal-type cell wall organization | GO_0031505 |
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the fungal-type cell wall.
|
| heterochromatin formation | GO_0031507 |
An epigenetic gene silencing mechanism in which chromatin is compacted into heterochromatin, resulting in a chromatin conformation refractory to transcription. This process starts with heterochromatin nucleation, its spreading, and ends with heterochromatin boundary formation.
|
| negative regulation of gene expression, epigenetic | GO_0045814 |
An epigenetic process that silences gene expression at specific genomic regions through chromatin remodelling either by modifying higher order chromatin fiber structure, nucleosomal histones, or the DNA.
|
| heterochromatin organization | GO_0070828 |
Any process that results in the specification, formation or maintenance of the physical structure of eukaryotic heterochromatin, a compact and highly condensed form of chromatin.
|
| isoleucine catabolic process | GO_0006550 |
The chemical reactions and pathways resulting in the breakdown of isoleucine, (2R*,3R*)-2-amino-3-methylpentanoic acid.
|
| leucine catabolic process | GO_0006552 |
The chemical reactions and pathways resulting in the breakdown of leucine, 2-amino-4-methylpentanoic acid.
|
| S-adenosylmethionine biosynthetic process | GO_0006556 |
The chemical reactions and pathways resulting in the formation of S-adenosylmethionine, S-(5'-adenosyl)-L-methionine, an important intermediate in one-carbon metabolism.
|
| S-adenosylmethionine metabolic process | GO_0046500 |
The chemical reactions and pathways involving S-adenosylmethionine, S-(5'-adenosyl)-L-methionine, an important intermediate in one-carbon metabolism.
|
| obsolete S-adenosylmethioninamine biosynthetic process | GO_0006557 |
OBSOLETE. The chemical reactions and pathways resulting in the formation of S-adenosylmethioninamine, (5-deoxy-5-adenosyl)(3-aminopropyl) methylsulfonium salt.
|
| GO_0006440 | GO_0006440 | |
| obsolete binding to mRNA cap | GO_0006441 |
OBSOLETE. (Was not defined before being made obsolete).
|
| GO_0006442 | GO_0006442 | |
| GO_0006443 | GO_0006443 | |
| GO_0006444 | GO_0006444 | |
| negative regulation of protein metabolic process | GO_0051248 |
Any process that stops, prevents, or reduces the frequency, rate or extent of chemical reactions and pathways involving a protein.
|
| GO_0006445 | GO_0006445 |